Published Date: 16 Sep 2023
With regard to sexual dysfunction, comorbid depression may be a factor in the more than 55% of men and 60% of women with schizophrenia.
Read Full NewsA new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and increased survival rates, many patients worldwide are not receiving the compassionate, holistic support ...
Glioblastoma is one of the most aggressive and complex brain cancers. It grows quickly, resists standard treatments, and often leaves patients and their families searching for every possible option.
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of overdiagnosis, or the detection ...
1.
Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC
2.
Breast cancer screening in women's 40s can save lives, study says
3.
Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.
4.
Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women
5.
findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.
1.
The Algorithmic Oncologist: A Comparative Clinical Review of AI in Predictive Cancer Planning
2.
Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts
3.
IL1R2 Inhibition: A New Strategy to Boost Cancer Immunity
4.
Targeted Therapies for Breast Cancer: What’s New?
5.
Uncovering the Mystery of the Sessile Serrated Adenoma
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
2.
Navigating the Complexities of Ph Negative ALL - Part XV
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
5.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation